Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

First‐trimester screening for Down syndrome with ductus venosus Doppler studies in addition to nuchal translucency and serum markers

20 Jul 2005

Abstract excerpt

OBJECTIVE: To estimate the improvement in screening efficiency when fetal ductus venosus Doppler studies are added to existing first-trimester Down syndrome screening protocols. METHODS: Statistical modelling was used with parameters derived from prospective ductus venosus studies and from the published literature. The pulsatility index for veins (PIV), was determined in the fetal ductus venosus for 3706...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Parvovirus B19 Infection Studies
Share to Pregnancy and preeclampsia studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16034840
DOI: 10.1002/pd.1203

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

First‐trimester screening for Down syndrome with ductus venosus Doppler studies in addition to nuchal translucency and serum markersPMID 16034840Read ↗

First trimester combined screening for fetal aneuploidies enhanced with additional ultrasound markers: an 8-year prospective study.Semantic proximity Read ↗

A Mixture Model of Ductus Venosus Pulsatility Index in Screening for Aneuploidies at 11–13 Weeks’ GestationSemantic proximity Read ↗

First‐trimester screening for fetal aneuploidy: biochemistry and nuchal translucencySemantic proximity Read ↗

First Trimester Genetic Sonogram for Screening Fetal Down Syndrome: a Population-based StudySemantic proximity Read ↗

First‐trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell‐free DNA testingSemantic proximity Read ↗

Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11–13 weeks of gestationSemantic proximity Read ↗

Ductus Venosus in the First Trimester: Contribution to Screening of Chromosomal, Cardiac Defects and Monochorionic Twin ComplicationsSemantic proximity Read ↗

First‐trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practiceSemantic proximity Read ↗

First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screeningSemantic proximity Read ↗

ACOG Practice Bulletin No. 77: Screening for Fetal Chromosomal AbnormalitiesSemantic proximity Read ↗

First-Trimester Screening for Trisomies 21, 18 and 13 by Ultrasound and Biochemical TestingSemantic proximity Read ↗

First-Trimester down syndrome screening using dried blood biochemistry and nuchal translucencySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.